title: Is lymphadenectomy justified in endometrial cancer?
abstract: Endometrial cancer has in the meantime become the most frequent malignant tumor of the female genital tract. With a 5-year survival rate of 82% for all stages and more than 90% for the most common stage I, it is a carcinoma with an excellent prognosis. Against this background and in light of the results of recent studies, the value of extensive surgical staging including pelvic and para-aortic lymphadenectomy beyond the standard therapy of hysterectomy with bilateral adnexectomy must be questioned.
authors: Department of Obstetrics and Gynecology, University of Wuerzburg, Wuerzburg, Germany. dietl_j@klinik.uni-wuerzburg.de
authors: Johannes
authors: J
authors: Dietl
mesh_terms: D002986:Clinical Trials as Topic; D016889:Endometrial Neoplasms / Q000473:pathology* / Q000601:surgery*; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D015996:Survival Rate